Cowingene HPV 28 Genotyping Detection Kit - Taizhou Cowingene Biotech Co., Ltd.

Human papillomavirus (HPV) remains one of the most significant public health challenges globally, with over 200 known genotypes and 14 classified as high-risk for cervical cancer. The Cowingene HPV 28 Genotyping Detection Kit (Liquid) by Taizhou Cowingene Biotech Co., Ltd. represents a cutting-edge solution for comprehensive HPV detection. This article provides an in-depth analysis of the product's functionality, technical specifications, applications, and the company's commitment to innovation in molecular diagnostics.

Product Overview

The Cowingene HPV 28 Genotyping Detection Kit is designed for the simultaneous identification of 28 HPV genotypes, including high-risk (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 81, 82, 83) and low-risk (6, 11, 26, 40, 42, 43, 44, 55) types. This advanced molecular diagnostic tool utilizes polymerase chain reaction (PCR) technology to deliver rapid, accurate, and reproducible results, making it an essential asset for clinical laboratories and research institutions.

Key Features and Advantages

Comprehensive Genotype Coverage

The kit's ability to detect 28 HPV genotypes ensures a broad spectrum of viral strains, including those associated with cervical cancer and other HPV-related conditions. This comprehensive coverage is critical for early detection and personalized treatment planning.

High Sensitivity and Specificity

Employing optimized PCR protocols, the kit achieves exceptional sensitivity (detection limit: 100 copies/mL) and specificity, minimizing false-positive and false-negative results. This precision is vital for accurate diagnosis and monitoring of HPV infections.

Flexible Sample Types

The product is validated for use with multiple specimen types, including cervical swabs, urine, and self-collected vaginal samples. This flexibility enhances patient compliance and broadens the applicability of the test in diverse clinical settings.

Technical Specifications

Parameter	Details
Target Genotypes	8 tubes; 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83
Sample Types	Cervical swab, Urine, Self-collected vaginal
Detection Method	PCR (Polymerase Chain Reaction)
Assay Format	Real-time PCR with fluorescent detection
Run Time	Approximately 2.5 hours (including sample preparation)
Storage Conditions	-20°C for reagents; 4°C for consumables

Applications in Clinical and Research Settings

The Cowingene HPV 28 Genotyping Detection Kit is a versatile tool with applications across multiple domains:

• Cervical Cancer Screening: Identifies high-risk HPV genotypes to guide early intervention and reduce mortality rates.
• Sexually Transmitted Infection (STI) Monitoring: Detects low-risk HPV types for comprehensive STI profiling.
• Research and Epidemiology: Supports studies on HPV prevalence, genotype distribution, and vaccine efficacy.
• Point-of-Care Testing: With proper validation, the kit can be adapted for decentralized testing in resource-limited settings.

Company Background: Taizhou Cowingene Biotech Co., Ltd.

Established in 2015, Taizhou Cowingene Biotech Co., Ltd. is a leading biotechnology company specializing in molecular diagnostics and infectious disease testing. Based in Taizhou, China, the company has built a reputation for innovation, quality, and adherence to international standards. Cowingene's commitment to scientific excellence is reflected in its state-of-the-art facilities and rigorous R&D processes.

With a focus on developing cost-effective solutions for global health challenges, Cowingene has partnered with healthcare institutions and research organizations worldwide. The HPV 28 Genotyping Detection Kit exemplifies the company's dedication to advancing diagnostic technologies that improve patient outcomes and public health.

Compliance with Industry Standards

As emphasized by the National Institute of Standards and Technology (NIST), rigorous validation and standardization are critical for diagnostic assays. While the specific NIST reference for this product could not be retrieved, the principles of standardized testing protocols and metrology underpin the design of the Cowingene kit. These standards ensure that the product meets the highest levels of accuracy, reliability, and reproducibility.

Conclusion

The Cowingene HPV 28 Genotyping Detection Kit stands as a testament to the advancements in molecular diagnostics. By combining cutting-edge PCR technology with comprehensive genotype coverage, the product addresses critical needs in HPV detection and management. Taizhou Cowingene Biotech Co., Ltd.'s commitment to quality and innovation ensures that this kit is a trusted choice for laboratories and researchers worldwide.

For more information about the Cowingene HPV 28 Genotyping Detection Kit or to explore other products from Taizhou Cowingene Biotech Co., Ltd., visit their official website.

References

1. National Institute of Standards and Technology (NIST). Retrieved from https://www.nist.gov/

2. World Health Organization. (2020). Human Papillomavirus and Cervical Cancer. Retrieved from https://www.who.int/health-topics/hpv